APO-Fluoxetine Product Recall (2015-08-25) Aug 25, 2015 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type II
Lot or serial number Brand name Companies Dosage form DIN, NPN, DIN-HIM Strength KZ8596 B. APO-Fluoxetine 20 mg Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Capsule DIN 02216361 Fluoxetine (Fluoxetine hydrochloride) 20 mg MC5453 A. APO-Fluoxetine 10 mg Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Capsule DIN 02216353 Fluoxetine (Fluoxetine hydrochloride) 10 mg
Affected Products
APO-Fluoxetine 10 mg
APO-Fluoxetine 20 mg
The active pharmaceutical ingredient (API) used in the manufacturing of these lots may not meet the specification for impurity- isobutyl vinyl ketone (IBVK)